Literature DB >> 9987672

Clinical applications of detecting dysfunctional p53 tumor suppressor protein.

I O Baas1, R H Hruban, G J Offerhaus.   

Abstract

The p53 gene encodes for a protein, p53, which plays a critical role in controlling the cell cycle, in DNA repair and in programmed cell death (apoptosis). p53 is one of the most frequently mutated genes in human neoplasms and a variety of techniques have been developed to detect these mutations. These range from advanced molecular-genetic analyses to immunohistochemical staining for the p53 protein. This review will summarize our current understanding of the function of p53 as well as current methods to detect dysfunctional p53 and the clinical value of such analyses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9987672     DOI: 10.14670/HH-14.279

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  4 in total

Review 1.  Pancreatic adenocarcinoma pathology: changing "landscape".

Authors:  Lodewijk A A Brosens; Wenzel M Hackeng; G Johan Offerhaus; Ralph H Hruban; Laura D Wood
Journal:  J Gastrointest Oncol       Date:  2015-08

2.  Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer.

Authors:  Sung Yong Oh; Hyuk-Chan Kwon; Sung-Hyun Kim; Jin Seok Jang; Min Chan Kim; Kyeong Hee Kim; Jin-Yeong Han; Chung Ock Kim; Su-Jin Kim; Jin-sook Jeong; Hyo-Jin Kim
Journal:  BMC Cancer       Date:  2008-05-01       Impact factor: 4.430

Review 3.  Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses.

Authors:  Joanna Obacz; Silvia Pastorekova; Borek Vojtesek; Roman Hrstka
Journal:  Mol Cancer       Date:  2013-08-14       Impact factor: 27.401

4.  Temperature-sensitive ovarian carcinoma cell line (OvBH-1).

Authors:  Julia K Bar; Antonina Harlozinska; Sabine Kartarius; Mathias Montenarh; Ewa Wyrodek; Jan M Rodriguez Parkitna; Marian Kochman; Andrzej Ozyhar
Journal:  Jpn J Cancer Res       Date:  2002-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.